REBOA in Nontraumatic OHCA
Condition(s) studied
Investigational drug(s) / intervention(s)
REBOA: Resuscitative endovascular balloon occlusion of the aorta (REBOA)is a device composed of a catheter attached to an inflatable balloon. It is inserted through the common femoral artery and guided to the thoracic aorta.
Study summary
The investigators propose a multicenter randomized controlled trial in South Korea and Taiwan to observe the clinical effects of REBOA on nontraumatic out-of-hospital-cardiac-arrest (OHCA) patients. While REBOA has been traditionally used in trauma for hemorrhage control, it has also shown promising results in nontraumatic cardiac arrests by rerouting circulation to increase perfusion in the coronary and brain.
Eligibility
Primary outcome measure(s)
- Number of Participants Who Achieved ROSC (return of spontaneous circulation) — 24 hours
Number of patients who achieves ROSC regardless of sustained time
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Seoul National Univeristy Bundang Hospital | Seongnam-si | Gyeonggi-do | Recruiting |
More Seoul National University Hospital trials in South Korea
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06031623 on ClinicalTrials.gov ↗ ← All trials in South Korea